Usa city Amsterdam World Usa city Amsterdam

EMA begins assessing Pfizer-BioNTech jab for 12-15 year olds

Reading now: 775

The European Medicines Agency has said it has begun evaluating the use of Pfizer-BioNTech's Covid-19 vaccine for those aged 12 to 15, after a similar request in the United States.

Its possible authorisation for children is seen as a crucial step towards achieving herd immunity. The EMA's human medicines committee "will carry out an accelerated assessment of data submitted by the company that markets Comirnaty," said an EMA statement - referring to vaccine's brand name.

This included results from a large ongoing clinical study involving adolescents from 12 years of age, the Amsterdam-based agency said.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News